Advertisement
Research Article

Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease

  • Caroline L. Benn,

    Affiliations: Department of Medical and Molecular Genetics, King's College London School of Medicine, King's College London, London, United Kingdom, Pfizer Regenerative Medicine, UCB Granta Park, Great Abington, Cambridge, United Kingdom

    X
  • Rachel Butler,

    Affiliations: Department of Medical and Molecular Genetics, King's College London School of Medicine, King's College London, London, United Kingdom, Nuffield Laboratory of Ophthalmology, University of Oxford, The John Radcliffe Hospital, Oxford, United Kingdom

    X
  • Lydia Mariner,

    Affiliation: Department of Medical and Molecular Genetics, King's College London School of Medicine, King's College London, London, United Kingdom

    X
  • Jude Nixon,

    Affiliation: Department of Medical and Molecular Genetics, King's College London School of Medicine, King's College London, London, United Kingdom

    X
  • Hilary Moffitt,

    Affiliation: Department of Medical and Molecular Genetics, King's College London School of Medicine, King's College London, London, United Kingdom

    X
  • Michal Mielcarek,

    Affiliation: Department of Medical and Molecular Genetics, King's College London School of Medicine, King's College London, London, United Kingdom

    X
  • Ben Woodman,

    Affiliation: Department of Medical and Molecular Genetics, King's College London School of Medicine, King's College London, London, United Kingdom

    X
  • Gillian P. Bates mail

    gillian.bates@kcl.ac.uk

    Affiliation: Department of Medical and Molecular Genetics, King's College London School of Medicine, King's College London, London, United Kingdom

    X
  • Published: June 01, 2009
  • DOI: 10.1371/journal.pone.0005747

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.